4D Molecular Therapeutics (FDMT) Prepaid Assets (2019 - 2026)

4D Molecular Therapeutics (FDMT) has 8 years of Prepaid Assets data on file, last reported at $14.5 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 30.04% year-over-year to $14.5 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 30.04% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 4.22% from the prior year.
• Prepaid Assets for Q1 2026 stood at $14.5 million, up from $10.5 million in the prior quarter.
• Over the last five years, Prepaid Assets for FDMT reached as high as $14.5 million in Q1 2026 and fell as low as $4.8 million in Q3 2022.
• Historically, Prepaid Assets has averaged $8.7 million across 5 years, with a median of $8.6 million in 2023.
• On a YoY basis, Prepaid Assets climbed as much as 87.8% in 2022 and fell as far as 17.73% in 2022.
• Year by year, Prepaid Assets stood at $7.0 million in 2022, then rose by 20.11% to $8.4 million in 2023, then grew by 20.33% to $10.1 million in 2024, then grew by 4.22% to $10.5 million in 2025, then jumped by 38.1% to $14.5 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $14.5 million in Q1 2026, $10.5 million in Q4 2025, and $7.3 million in Q3 2025.